Physician profile
David A Fish
NPI 1124150685
$1,652.08
in general payments reported to CMS, 2019-2025
11 companies · $372 in 2025
The $372 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.84 · 2020: $56.78 · 2021: $447 · 2022: $146 · 2023: $299 · 2024: $313 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $865.92 | 2021-2025 | Epic |
| Edwards Lifesciences Corporation | $299.42 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $180.84 | 2021-2025 | Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $110.56 | 2022-2023 | Watchman Access System |
| Merck Sharp & Dohme LLC | $42.99 | 2020-2024 | Bridion |
| Mindray Ds USA, INC. | $40.84 | 2022 | |
| Ethicon US, LLC | $34.56 | 2020 | |
| Atricure, INC. | $29.49 | 2023 | |
| Ge Healthcare | $19.73 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.84 | 2019 | |
| Ambu INC. | $8.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.